Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CNTB Connect Biopharma Holdings Ltd.

Trading 07-27 14:11:28 EDT

2.17

+0.03

+1.40%

High2.20	Low2.08	Vol126.55K
Open2.15	D1 Closing2.14	Amplitude5.61%
Mkt Cap136.63M	Tradable Cap40.90M	Total Shares62.96M
T/O271.12K	T/O Rate0.67%	Tradable Shares18.85M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"Connect Biopharma Holdings Ltd.","latestPrice":2.17,"timestamp":1785175884855,"preClose":2.14,"halted":0,"volume":126549,"delay":0,"changeRate":0.014018691588784955,"floatShares":18850000,"shares":62963853,"eps":-1.154539,"marketStatus":"Trading","change":0.03,"latestTime":"07-27 14:11:28 EDT","open":2.15,"high":2.2,"low":2.08,"amount":271118.7927333,"amplitude":0.056075,"askPrice":2.2,"askSize":600,"bidPrice":2.15,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.154539,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785182400000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":2.14,"preHourTrading":{"tag":"盘前","latestPrice":2.1856,"preClose":2.14,"latestTime":"09:18 EDT","volume":1947,"amount":4219.4819370000005,"timestamp":1785158297328,"change":0.0456,"changeRate":0.021308,"amplitude":0.053271},"postHourTrading":{"tag":"盘后","latestPrice":2.15,"preClose":2.14,"latestTime":"19:42 EDT","volume":4463,"amount":9860.2834,"timestamp":1784936570376,"change":0.01,"changeRate":0.004673,"amplitude":0.060748},"volumeRatio":0.567783,"impliedVol":1.4918,"impliedVolPercentile":0.6534},"requestUrl":"/m/hq/s/CNTB/tweets","defaultTab":"tweets","newsList":[{"id":"2651140176","title":"Connect Biopharma Posts Investor Presentation Highlighting Rademikibart Program in Asthma, COPD Exacerbations","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140176","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140176?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:22","pubTimestamp":1783988575,"startTime":"0","endTime":"0","summary":"Connect Biopharma posts investor presentation highlighting rademikibart program in asthma, COPD exacerbationsConnect Biopharma highlighted rademikibart, an anti-IL-4Rα antibody, as its lead program fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL7JVzRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892120","title":"Connect Biopharma Holdings Ltd : Oppenheimer Initiates Coverage with Outperform Rating; Target Price $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650892120?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:26","pubTimestamp":1783600018,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B0W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646368243","title":"Connect Biopharma Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2646368243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646368243?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:55","pubTimestamp":1782482100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings(END) Dow Jones NewswiresJune 26, 2026 09:55 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646332593","title":"Connect Biopharma Holdings Ltd : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2646332593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646332593?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:38","pubTimestamp":1782459495,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42Y0BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646133434","title":"U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646133434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646133434?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:06","pubTimestamp":1782457590,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-American Tower, H.B. Fuller Company, TD SynnexJune 26 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4N42Y0ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAL","DRI","ALGT","CROX","CNTB","DAL","FTH","CALY","GOLF","AALG","A","FDXF","AIT","EXPD","BNY","BDC","AVAV","ESTC","IE00BD4GTW91.USD","AR","AVTR","GH","CUZ","CMC","CSX","AVXX","LU0011850046.USD","ALLY","BAC","ESS","EPR","BRO","LU0477156953.USD","AMT","SNX","CTSH","TECH","DYN","LU0648001328.SGD","LU0347712357.USD","BHVN","LU2413666699.HKD","ACNB","AMAT","ALK","BNED","ACA","AMH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646808250","title":"Connect Biopharma Price Target Maintained with a $7.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2646808250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646808250?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:42","pubTimestamp":1782391320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings(END) Dow Jones NewswiresJune 25, 2026 08:42 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644005157","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Alkermes (ALKS) and Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644005157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644005157?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:51","pubTimestamp":1781779869,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Butterfly Network (BFLY), Alkermes (ALKS) and Connec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-alkermes-alks-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-alkermes-alks-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0029874061.USD","BK4139","XBI","BK4137","BK4082","BFLY","XLV","BK4581","BK4588","CNTB","LABU","BK4585","LU0128526141.USD","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644413357","title":"Connect Biopharma Completes Enrollment in Phase 2 Rademikibart Asthma Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2644413357","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644413357?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:31","pubTimestamp":1781703088,"startTime":"0","endTime":"0","summary":"Connect Biopharma  has completed enrollment in its Phase 2 Seabreeze STAT asthma study evaluating rademikibart for acute asthma exacerbations, the company said Wednesday.The randomized, placebo-controlled study enrolled 160 participants globally and is evaluating the safety and efficacy of the IL-4R alpha antibody as an adjunct to standard of care in patients with type 2 inflammation, the company said.Connect Biopharma said it remains on track to complete enrollment in a related COPD study this month and expects to report topline asthma data in early September 2026.Shares of the company were up 4.5% in premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644749617","title":"Connect Biopharma - to Report Topline Data From Seabreeze Stat Asthma Study in Early September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749617?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:00","pubTimestamp":1781701204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA1YLGDF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644374982","title":"Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze Stat Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2644374982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644374982?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:00","pubTimestamp":1781701204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA1YLGDF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638544567","title":"H.C. Wainwright Reaffirms Their Buy Rating on Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638544567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638544567?lang=en_us&edition=fundamental","pubTime":"2026-05-27 01:50","pubTimestamp":1779817858,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Connect Biopharma Holdings today and set a price target of $7.00. According to Ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516336","title":"Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516336","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516336?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:51","pubTimestamp":1779792714,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings (CNTB) has an average rating of buy and mean price target of $7.08, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638518521","title":"Connect Biopharma initiated with a Buy at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2638518521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638518521?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:25","pubTimestamp":1779787505,"startTime":"0","endTime":"0","summary":"Canaccord analyst Edward Nash initiated coverage of Connect Biopharma (CNTB) with a Buy rating and $6 price target Published first on TheFly – the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-a-buy-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-a-buy-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637233236","title":"Connect Biopharma Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2637233236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637233236?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:23","pubTimestamp":1779373380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2026 10:23 ET (14:23 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382344","title":"Connect Biopharma initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382344?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:11","pubTimestamp":1779358298,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Olivia Brayer initiated coverage of Connect Biopharma (CNTB) with an Overweight rating and $4 price target Published firs...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635903668","title":"Connect Biopharma files to sell 6.13M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2635903668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635903668?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:43","pubTimestamp":1778859834,"startTime":"0","endTime":"0","summary":"08:33 EDT Connect Biopharma (CNTB) files to sell 6.13M ordinary shares for holders Published first on TheFly – the ultimate source for real-time, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-files-to-sell-6-13m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-files-to-sell-6-13m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084011","title":"Connect Biopharma Holdings Ltd - Proposed Resale of up to 6.1 Mln Ordinary Shares of Connect Biopharma - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635084011?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:33","pubTimestamp":1778848387,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S13I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635754597","title":"Connect Biopharma posts corporate presentation on rademikibart development in asthma, COPD, atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2635754597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635754597?lang=en_us&edition=fundamental","pubTime":"2026-05-14 06:46","pubTimestamp":1778712417,"startTime":"0","endTime":"0","summary":"Connect Biopharma outlined development plans for rademikibart, an anti-IL-4Rα monoclonal antibody with global rights outside greater China.Phase 2 studies in acute COPD and asthma exacerbations started in 2Q2025, with topline data expected in mid-2026; study is being run by Simcere at no cost to Connect.Simcere filed an NDA in China for atopic dermatitis in July 2025.U.S. FDA agreed rademikibart is ready to move into Phase 3 for chronic treatment of asthma and atopic dermatitis, based on results from completed studies.Presentation highlighted clinical and preclinical comparisons versus dupilumab, including a reported reduction in eosinophils in asthma patients and potential for less frequent dosing in atopic dermatitis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL3LV6qv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635000172","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2635000172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635000172?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:00","pubTimestamp":1778666400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Copa Hldgs A                                     1Q      4.14    4:30 PM. ·FLEX LNG Ltd                                    1Q       .36    1:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","BBWI","ALLO","CELC","ACOG","BEEM","PYPD","AYTU","CLNN","AEBI","CBUS","BEAT","BGSI","CCCC","AUTL","CCAP","ATYR","CMPS","DERM","CSWC","ALT","BWAY","BIRK","BTDR","BN","BTBT","CLPT","CNTB","CSCO","BABA","CING","BHST","BOOT","CLBT","BTGO","CPA","BZAI","ATAT","AKA","KARO","PHVS","AMAT","ATS","BLSH","CAAP","ARX","AQST","CSIQ","AVAH","GOOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635425246","title":"Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2635425246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635425246?lang=en_us&edition=fundamental","pubTime":"2026-05-13 00:36","pubTimestamp":1778603778,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Connect Biopharma Holdings, with a price target of $7.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/connect-biopharma-holdings-cntb-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/connect-biopharma-holdings-cntb-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.connectbiopharm.com","stockEarnings":[{"period":"1week","weight":-0.1008},{"period":"1month","weight":0.0094},{"period":"3month","weight":-0.1508},{"period":"6month","weight":-0.1575},{"period":"1year","weight":-0.0894},{"period":"ytd","weight":-0.2411}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.028496},{"month":2,"riseRate":0.6,"avgChangeRate":-0.025044},{"month":3,"riseRate":0.4,"avgChangeRate":-0.062942},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.024639},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.059238},{"month":6,"riseRate":0.666667,"avgChangeRate":0.069047},{"month":7,"riseRate":0.333333,"avgChangeRate":0.108754},{"month":8,"riseRate":0.8,"avgChangeRate":0.204473},{"month":9,"riseRate":0.2,"avgChangeRate":-0.084295},{"month":10,"riseRate":0.4,"avgChangeRate":0.007717},{"month":11,"riseRate":0.2,"avgChangeRate":-0.108453},{"month":12,"riseRate":1,"avgChangeRate":0.142382}],"exchange":"NASDAQ","name":"Connect Biopharma Holdings Ltd.","nameEN":"Connect Biopharma Holdings Ltd.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Connect Biopharma Holdings Ltd.(CNTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Connect Biopharma Holdings Ltd.,CNTB,Connect Biopharma Holdings Ltd.股票,Connect Biopharma Holdings Ltd.股票老虎,Connect Biopharma Holdings Ltd.股票老虎国际,Connect Biopharma Holdings Ltd.行情,Connect Biopharma Holdings Ltd.股票行情,Connect Biopharma Holdings Ltd.股价,Connect Biopharma Holdings Ltd.股市,Connect Biopharma Holdings Ltd.股票价格,Connect Biopharma Holdings Ltd.股票交易,Connect Biopharma Holdings Ltd.股票购买,Connect Biopharma Holdings Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Connect Biopharma Holdings Ltd.(CNTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction